Cargando…

Drugs that Might Be Possibly Used for Treatment of COVID-19 Patients

The drug development process for Coronavirus disease (COVID-19) is the research process to create a preventive vaccine or therapeutic prescription drug to relieve the severity of 2019–2020 (COVID-19). In different stages of preclinical or clinical research, several hundred special scientific researc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zahraa Talib Khudhair, Shihab, Mehdi Salih, Hamah-Ameen, Baram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pleiades Publishing 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380022/ https://www.ncbi.nlm.nih.gov/pubmed/34456540 http://dx.doi.org/10.1134/S1068162021040130

Ejemplares similares

Preparation of quinazolinones using biosynthesized silver nanoparticles
por: Safaei-Ghomi, Javad, et al.
Publicado: (2022)

Dengue After COVID-19 Vaccination: Possible and Might be Missed
por: Kebayoon, Amnuay, et al.
Publicado: (2021)

Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
por: Calpe-López, Claudia, et al.
Publicado: (2019)

Time travel might really be possible
Publicado: (2009)

Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups
por: Alazzawi, Haneen F., et al.
Publicado: (2021)

Brief review on repurposed drugs and vaccines for possible treatment of COVID-19
por: De, Priyasha, et al.
Publicado: (2021)

Self-burning in Iraqi Kurdistan: proportion and risk factors in a burns unit
por: Mohammad Amin, Nazar M., et al.
Publicado: (2012)

A Vision of the Possible. What the R.A.M.C. Might Become
Publicado: (1919)

ARB might be superior to ACEI for treatment of hypertensive COVID‐19 patients
por: Zhao, Hong‐Jin, et al.
Publicado: (2021)

The effect of different levels of pre-damage loading on the strength and structural behavior of CFRP strengthened R.C. beams: Experimental and analytical investigation
por: Hamah-Ali, Brwa Hamah Saeed, et al.
Publicado: (2021)

COVID-19, social media use and anxiety: more complex than it might appear?
por: Newton, Tim
Publicado: (2021)

The evaluation results of proposed antigen rapid diagnostic tests for COVID-19: some possible factors might influence
por: Juniastuti, et al.
Publicado: (2023)

COVID-19: When more might be less
por: Mugnai, Giacomo, et al.
Publicado: (2021)

Chemotherapeutic Drug-Regulated Cytokines Might Influence Therapeutic Efficacy in HCC
por: Wang, Chun-I, et al.
Publicado: (2021)

COVID-19 and IL-6: Why vitamin D (probably) helps but tocilizumab might not
por: Silberstein, Morry
Publicado: (2021)

Imatinib might constitute a treatment option for lung involvement in COVID-19
por: Bernal-Bello, David, et al.
Publicado: (2020)

Why the application of IVIG might be beneficial in patients with COVID-19
por: Kindgen-Milles, Detlef, et al.
Publicado: (2022)

Tetracycline and viruses: a possible treatment for COVID-19?
por: Mosquera-Sulbaran, Jesús A., et al.
Publicado: (2020)

Remote Monitoring of COVID-19 Patients Using Multisensor Body Area Network Innovative System
por: Al-Barazanchi, Israa, et al.
Publicado: (2022)

Pharmacological rationale for antihypertensive drug choice on COVID‐19–affected patients: ACEI/ARB might not increase their susceptibility
por: Zhao, Hong‐Jin, et al.
Publicado: (2020)

Amphotericin B as antiviral drug: Possible efficacy against COVID-19
por: AL-Khikani, Falah Hasan Obayes
Publicado: (2020)

Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19
por: Rabie, Amgad M.
Publicado: (2021)

The COVID-19 pandemic in the USA: what might we expect?
por: Chowell, Gerardo, et al.
Publicado: (2020)

RETRACTED: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Colchicine use might be associated with lower mortality in COVID‐19 patients: A meta‐analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2021)

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis
por: Lucijanic, Marko, et al.
Publicado: (2022)

Biomarkers for Sepsis: What Is and What Might Be?
por: Biron, Bethany M., et al.
Publicado: (2015)

Diaphragm Muscle Weakness Might Explain Exertional Dyspnea 15 Months after Hospitalization for COVID-19
por: Regmi, Binaya, et al.
Publicado: (2023)

Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa—Possibilities and Limitations
por: Świerczewska, Zuzanna, et al.
Publicado: (2022)

COVID-19-induced surge in the severity of gender-based violence might increase the risk for acquired brain injuries
por: Saleem, Ghazala T, et al.
Publicado: (2021)

Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
por: Kelleni, Mina T.
Publicado: (2021)

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
por: Rezaee, Haleh, et al.
Publicado: (2021)

Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features
por: Rommasi, Foad, et al.
Publicado: (2022)

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19
por: Orienti, Isabella, et al.
Publicado: (2020)

Insights on Epidemiology, Pathogenesis, Diagnosis and Possible Treatment of COVID-19 Infection
por: Maurya, Shashank Kumar, et al.
Publicado: (2022)

High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients
por: Rodríguez de la Concepción, María Luisa, et al.
Publicado: (2021)

Why the application of IVIG might be beneficial in patients with COVID-19 – Authors' reply
por: Mazeraud, Aurélien, et al.
Publicado: (2022)

Chronic Inflammation Might Protect Hemodialysis Patients From Severe COVID-19
por: Prietl, Barbara, et al.
Publicado: (2022)

Air pollution might affect the clinical course of COVID-19 in pediatric patients
por: Rzymski, Piotr, et al.
Publicado: (2022)

Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders
por: Alkan, Arif, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e08vks3h2364l5avfhos64j2rc